THE SECRETS OF MRSA CONTROL IN THE NETHERLANDS. Margreet C. Vos Medical Microbiology and Infectious Diseases Erasmus MC, Rotterdam, the Netherlands

Similar documents
MRSA in Holland What is Behind the Success Gertie van Knippenberg-Gordebeke

MRSA and Nursing homes: Is there a problem and do we need to change our guidelines?

The Role of Isolation and Contact Precautions in the Elimination of Transmission of MRSA

Systems to evaluate environmental cleanliness

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 3 Strategies to prevent

Infection Control and Prevention On-site Review Tool Hospitals

BEHAVIORAL HEALTH & LTC. Mary Ann Kellar, RN, MA, CHES, IC March 2011

Approval Signature: Date of Approval: December 6, 2007 Review Date:

Investigating Clostridium difficile Infections

INFECTION C ONTROL CONTROL CONTROL EDUCATION PROGRAM

Running head: THERAPEUTIC NURSING 1

Checklists for Preventing and Controlling

Infection Control Readiness Checklist

Single room with negative pressure ventilation in relation to surrounding areas

Infection Prevention & Control February 22-23, 2017 Sheraton Hotel, Manama, Bahrain

Protocol for the Prevention and Management of Clostridium difficile.

IC CONTACT and CONTACT PLUS PRECAUTIONS REV. JULY 2017

Models for the organisation of hospital infection control and prevention programmes B. Gordts

8. Droplet/Contact Precautions. 8.1 Introduction

Direct cause of 5,000 deaths per year

Practical Aspects of TB Infection Control

Vancomycin-Resistant Enterococcus (VRE)

Outbreak Investigation Guidance for Community-Acquired MRSA

Infection prevention & control

Outbreak Management 2015

Kristi Felix RN, BSN, CRRN, CIC, FAPIC Infection Prevention Coordinator Madonna Rehabilitation Hospitals

Enterobacteriaceae. Preventing the Spread of Carbapenemresistant. in LTCFs. Nimalie D. Sto ne, MD, MS CDC Division of Healthcare Quality Promotion

Administrative Without, TB control fails. TB Infection Control What s New? Early disease prevention Modern cough etiquette

Infection Control Manual. Table of Contents

Validation of Environmental Cleanliness

Policy Objective To provide Healthcare Workers with details of the precautions necessary to minimise the risk of RSV cross-infection.

Incident Planning Guide: Infectious Disease

Clostridium difficile Algorithms for Long-term Care

Oregon Health & Science University Department of Surgery Standard Precautions Policy

Beth Ann Ayala, Jim Lewis, and Tom Patterson DATE. Educating for Quality Improvement & Patient Safety

Clostridium difficile Colonization in Ontario (COLON): Acute Care Hospital Pilot Feasibility Study, Preliminary Findings

Healthcare Associated Infections Know No Boundaries: A View Across the Continuum of Care

Clostridium difficile Infection (CDI) Trigger Tool

Learning Objectives. John T. Mather Memorial Hospital

Organizational Structure Ossama Rasslan

Erlanger Infection Control Program. Resident Resident Orientation and. and

Self-Instructional Packet (SIP)

Risk Assessment for the TB Laboratory

Too Posh to Wash. Too Posh to Wash Martin Kiernan, Southport and Ormskirk NHS Trust Teleclass broadcast sponsored by GOJO

Oxford University NHS Trust Infection Control Policy for Adults and Children with Cystic Fibrosis

Developed in response to: Best Practice Infection Prevention and Control

Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE) 2012 CRE Toolkit

WORKER PROTECTION AGAINST M. TUBERCULOSIS IN PATIENT CARE, DIAGNOSIS AND PATHOLOGY

TRUST POLICY AND PROCEDURES FOR CARBAPENEM RESISTANT ENTEROBACTERIACEAE (CRE) AND CARBAPENEM RESISTANT ORGANISMS (CRO)

Infection Control Policy and Procedure Manual. Post-Anesthesia Care Unit (Recovery Room) Page 1 of 6

Nosocomial infections. Nosocomial infections. Hosted by Paul Webber A Webber Training Teleclass

Standard Operating Procedure for Community Event-Based Surveillance for Ebola Virus Disease in Sierra Leone

Prevention and Control of Carbapenem Resistant Enterobacteriaceae Infections

Hereford Hospitals NHS Trust

WHO policy on TB infection control in health care facilities, congregate settings and households.

Recommendations for Isolation Precaution Step Down and Discharge of Persons Under Investigation or Confirmed Ebola Virus Disease Patients

Building a tutorial on safe use of personal protective equipment

Infection Prevention and Control in Ambulatory Care Settings: Minimum Expectations for Safe Care

Contact. EUCIC basic module Infection Prevention and Control Groningen, Netherlands 25 February 2 March 2018

Infection Control and Prevention On-site Review Tool Hospitals

INFECTION CONTROL POLICY DATE: 03/01/01 REVISED: 7/15/09 STATEMENT

Management of Scabies in Health and Social Care Settings

HCAI Local implementation team action plan

MRSA INFORMATION LEAFLET for patients and relatives. both in hospital and the community. MRSA is a type of

The Physician's Role in Controlling MRSA in Healthcare Settings

The Growing Threat of Antibiotic Resistance in Post-Acute Care

Infection Prevention & Exposure Control Online Orientation. Kimberly Koerner RN, BSN Associate Health Nurse

Infection Control Prevention Strategies. For Clinical Personnel

Infection Prevention, Control & Immunizations

Hope Is Not a Plan. Angela Hewlett, MD Associate Professor, UNMC Division of Infectious Diseases Medical Director, Nebraska Biocontainment Unit

To provide a comprehensive, integrated written policy to prevent or minimize employee exposures to tuberculosis (TB).

Infection Control Manual. Table of Contents

Skin and Nasal Decolonization for Adult

TB Transmission Risk Reduction

Take Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home

1/28/2014. Take Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home. Thank you to AANAC

Clean Care Is Safer Care and the WHO Guidelines on Hand Hygiene in Health Care

Preventing Hospital Acquired Infections: Clostridium difficile

Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas

Summary of updated health protection legislation (England)

Identify patients with Active Surveillance Cultures (ASC)

Response and measures following identification of a case of MERS-CoV infection in Norway. Fagseminar om MERS-CoV 25.

Infection Prevention Isolation Precautions Toolkit

Clinical Research in Antibiotic Resistance

Principles of Infection Prevention and Control

TUBERCULOSIS INFECTION CONTROL

Infectious Disease Plan. Introduction. Purpose: Primary Office: Secondary/Support Agencies:

The most up to date version of this policy can be viewed at the following website:

5/9/17. Healthcare-Associated Infections Cultural Shift. Background. Disclosures and Disclaimers

Guidelines for the Management of Norovirus Outbreaks in Acute and Community Health and Social Care Settings

NOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION

Lightning Overview: Infection Control

ACG GI Practice Toolbox. Developing an Infection Control Plan for Your Office

Translating Evidence to Safer Care

INFECTION PREVENTION AND CONTROL PROGRAM DESCRIPTION, OUTLINES & OBJECTIVES THE MINISTRY OF HEALTH, SAUDI ARABIA 23 RD 27 TH OCTOBER 2016

Nosocomial Infection in a Teaching Hospital in Thailand

August 22, Dear Sir or Madam:

How to Add an Annual Facility Survey

Accreditation Program: Hospital

WHEREAS, Ebola Virus Disease (EVD) is a rare and potentially deadly disease caused

Transcription:

THE SECRETS OF MRSA CONTROL IN THE NETHERLANDS Margreet C. Vos Medical Microbiology and Infectious Diseases Erasmus MC, Rotterdam, the Netherlands

MRSA - learning from the best Are we the best? Why are we the best? The practice of S&D Proposal to the UK Government Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

MRSA - learning from the best Are we the best? Why are we the best? Proposal to the UK Government Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

SEARCH AND DESTROY BY: - early detection - early identification and containment of the reservoir - reservoir: patients, HCWs,, environment HOW: isolation of patients proven AND at risk screening of asymptomatic carriers cohorting of patients and personnel eradication of carriership education of personnel desinfection

CRITICAL SUCCESS FACTORS: NATIONAL National policy proclaimed benchmark by Health Inspectorate National laboratory guideline on detection of MRSA National guideline for transporting patients from abroad Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

CRITICAL SUCCESS FACTORS: local Infection control committees All hospitals implement national policy Infection control facilities Trained HCWs

MRSA WIP guideline 2003: SEARCH AND DESTROY Risk classification of patients and HCWs Class A: proven carriers of MRSA Class B: high risk of being MRSA carrier Class C: increased risk of carrying MRSA Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

MEASURES: : PATIENTS Class A (proven) & B (high risk): Strict isolation upon admission always gloves, gowns, masks, caps Cohort nursing Class A: Notification in computer system Screen class B patients (multiple sites!) Class A: treatment as soon as possible Class C (increased( risk) : Screen and limit contact (single room) untill proven negative

MEASURES: HCWs Class A : Proven positive Banned from work With skin laesions: until proven negative No skin laesions: until 2 days after R screening for 1 year after treatment Class B : High risk culture only work on their own department until proven negative Class C : Increased risk (worked abroad) culture, no limitations

OUTBREAK MANAGEMENT: THE UNEXPECTED PATIENT Roommates: strict isolation (class B) ALL other patients on same ward: culture, but no isolation (class C) discharged patients: culture, swabs sent by post Compliance 90-95% 95% Effectiveness controlled by laboratory HCWs: : class C (culture)

THE SECOND MRSA : MRSA outbreak committee Ward is closed for admissions No entrance without gown, gloves, cap, mask Personnel stay on closed wards (lunch etc) Daily disinfection of rooms and passage Culture round (patients and HCWs) ) is repeated with each new finding Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

CLOSED WARDS: opened after: 1. All personnel 2. All patients are proven negative AND after Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

And after: 3. Disinfection of the entire ward disposal of all not-disinfected paraphernalia Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

Feasible in lowendemicity situations Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

MRSA in the community: PREVALENCE DATA Dutch prevalence rate 2000-2002: 2002: 0-0.06% 0 0.06% UK prevalence rate: 2001: 1.5% Abudu et al: Epidemiol.. Infect. 2001, 126, 351-6) de novo strains in the community: PVL+, SCCmec IV Outbreaks: Denmark,USA Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

MRSA - learning from the best Are we the best? Why are we the best? Proposal to the Government Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

Search & Destroy a plethora of measures not evidence-based? Or empiric measures that do work? Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

S & D lacks evidence but this is not an argument to stop successful strategies and not to start a successful strategy? Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

Proposal to the Government: basic principles Half-hearted practices and following guidelines: failure and frustration Use common sense and observational studies

Proposal to the Government starting points and basic principles Include all 3 reservoirs: minimize risk on transmission 1. Patient 2. and HCW: early detection, early isolation, early treatment 3. Environment Desinfection Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

Proposal to the Government controlled prospective "case-control" control" study: two arms Cases: treated arm Regions with S&D in all HCCs Controls: No change in infection control Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

Case-Control: Control: where? Region: defined large geographic area where patients receive their health care and where health service is adherent selection for case regions: new hospitals and or low(er) ) bed occupancy? Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands

Cases-Control: how? 3 RESERVOIRS Debulking phase: 6 months MRSA+: input Patients: 2-5% 2 HCW: 5-10% 5 Select High risk groups Health care centers: Reservoir and mutiplication areas Test high risk patients: Cohorting, isolation and treat proven cases only once screening HCW: cohorting Desinfection after dismission positive cases MRSA+: output Patients: 10-15% 15% HCW: 5-10% 5 Patients receive health care in nearby centers Transmission in the community: 50% in households

Cases-Control: how? 3 RESERVOIRS Fine tuning phase: years MRSA+: input Patients: 0-4% 0 HCW: 5% Select High risk groups Health care centers: Reservoir and mutiplication areas Start with treatment HCWs Cohorting high risk groups pending results Cohorting HCWS Screen all admissions Screen HCWs on a regular base Isolation and treatment Desinfection after dismission positive cases MRSA+: output Patients: 1% HCW: 1% Patients receive health care in nearby centers Transmission in the community: 50% in households

Proposal to the Government "Case regions": subdivision within hospitals into: -proven negative -proven positive -pending results for patients, HCWs,, materials, diagnostics etc: cohort nursing Active surveillance on definite negative dept.

Proposal to the Government Needed: isolation facilities rapid detection techniques: hours, real time PCR national guideline: definitions, risk classes, measures electronic warning of positive patients reference laboratory and molecular typing motivation education investment

UK: E-MRSAE Experiences what happened if no uniform strategy and/or facilities are not sufficient JID 1999;179;883-91

Case-Control: Control: Why? Taking < 3 reservoirs or include part of a hospital/region: Proven not to be successful: Cepeda,, Lancet online: 7 january 2005 patients/icu Evidence is needed: Cooper et al BMJ 2004: Conclusion: Current isolation measures recommended in national guidelines should continue to be applied until further research establishes otherwise.

The Patient Solberg, Scand J Infect Dis 32: 587± 595, 2000

The environment Journal of Hospital Infection (2004) 56, 191 197 J Hosp Infection 2002 51: 140-3

J Hosp Infection 2001 49: 255-61

The HCW: a source

HCW: a reservoir Farrington et al, Q J Med,, 1998

War against MRSA evidence based? We cannot give you the evidence, but you can! Margreet C. Vos. Jan 2005, Erasmus MC, Rotterdam the Netherlands